First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy
Clinical trial NCT04360434 · COMPLETED
Trial details
- NCT number
- NCT04360434
- Sponsor
- Neurimmune AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-10
- Primary completion
- 2023-07-26
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.